Literature DB >> 27511749

Case of CML lymphoid blast crisis presenting as bilateral breast masses.

Aneesha Hossain1, Kanika Gupta1, Andrew Mener2, Imad Tabbara2.   

Abstract

A woman aged 42 years with a 1-month history of rapidly expanding bilateral breast masses presented with severe leucocytosis, anaemia, blurry vision, headaches and shortness of breath. Evaluation revealed chronic myeloid leukaemia in lymphoid blast crisis with extramedullary leukaemia involving her breasts. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27511749      PMCID: PMC4985996          DOI: 10.1136/bcr-2016-215825

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Isolated relapse of acute lymphoblastic leukemia in the breast masquerading as gynecomastia.

Authors:  C S Chim; T W Shek; R Liang
Journal:  Am J Med       Date:  2000-06-01       Impact factor: 4.965

2.  Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

Authors:  Alice Fabarius; Armin Leitner; Andreas Hochhaus; Martin C Müller; Benjamin Hanfstein; Claudia Haferlach; Gudrun Göhring; Brigitte Schlegelberger; Martine Jotterand; Andreas Reiter; Susanne Jung-Munkwitz; Ulrike Proetel; Juliana Schwaab; Wolf-Karsten Hofmann; Jörg Schubert; Hermann Einsele; Anthony D Ho; Christiane Falge; Lothar Kanz; Andreas Neubauer; Michael Kneba; Frank Stegelmann; Michael Pfreundschuh; Cornelius F Waller; Karsten Spiekermann; Gabriela M Baerlocher; Michael Lauseker; Markus Pfirrmann; Joerg Hasford; Susanne Saussele; Rüdiger Hehlmann
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

Review 3.  Leukemic infiltration of the breast in acute lymphocytic leukemia (ALL).

Authors:  Merat Karbasian-Esfahani; Peter H Wiernik; Mrilini Yeddu; Lool Abebe
Journal:  Hematology       Date:  2008-04       Impact factor: 2.269

4.  The karyotype of blastic crisis.

Authors:  G Alimena; M R De Cuia; D Diverio; R Gastaldi; M Nanni
Journal:  Cancer Genet Cytogenet       Date:  1987-05

5.  How I treat CML blast crisis.

Authors:  Rüdiger Hehlmann
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

6.  Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

Authors:  Kimmo Porkka; Perttu Koskenvesa; Tuija Lundán; Johanna Rimpiläinen; Satu Mustjoki; Richard Smykla; Robert Wild; Roger Luo; Montserrat Arnan; Benoit Brethon; Lydia Eccersley; Henrik Hjorth-Hansen; Martin Höglund; Hana Klamova; Håvar Knutsen; Suhag Parikh; Emmanuel Raffoux; Franz Gruber; Finella Brito-Babapulle; Hervé Dombret; Rafael F Duarte; Erkki Elonen; Ron Paquette; C Michel Zwaan; Francis Y F Lee
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

7.  BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.

Authors:  Mateusz Koptyra; Rafal Falinski; Michal O Nowicki; Tomasz Stoklosa; Ireneusz Majsterek; Margaret Nieborowska-Skorska; Janusz Blasiak; Tomasz Skorski
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

Review 8.  Chronic myeloid leukaemia as a model of disease evolution in human cancer.

Authors:  Junia V Melo; David J Barnes
Journal:  Nat Rev Cancer       Date:  2007-06       Impact factor: 60.716

9.  Giant breast involvement in acute lymphoblastic leukemia: MRI findings.

Authors:  Isil Basara; Sebnem Orguc
Journal:  J Breast Cancer       Date:  2012-06-28       Impact factor: 3.588

10.  Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia.

Authors:  Ajay Gogia; Prashant Mehta; Raja Pramanik; Rajive Kumar
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

View more
  1 in total

1.  B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the Literature.

Authors:  Alisha D Ware; Laura Wake; Patrick Brown; Jonathan A Webster; B Douglas Smith; Amy S Duffield
Journal:  AJSP Rev Rep       Date:  2019 Sep-Oct
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.